Literature DB >> 19539780

Reduction of oxidative stress does not attenuate the development of angiotensin II-dependent hypertension in Ren-2 transgenic rats.

Libor Kopkan1, Zuzana Husková, Zdenka Vanourková, Monika Thumová, Petra Skaroupková, Jan Malý, Herbert J Kramer, Pavel Dvorák, Ludek Cervenka.   

Abstract

Results of our previous studies have suggested that enhanced generation of superoxide (O2(-)) may contribute to the pathophysiology of hypertension in Ren-2 transgenic rats (TGR). The present study was performed to evaluate in TGR the effects of chronic treatment with the O2(-) scavenger tempol and the antioxidant apocynin on the development of hypertension. Systolic blood pressure (SBP) was monitored from 30 to 99 days of age in TGR and in normotensive Hannover Sprague-Dawley (HanSD) rats. At the end of the experiment, urinary protein and 8-isoprostane excretion were determined and angiotensin II (ANG II) and malondialdehyde (MDA) levels were measured in kidney and cardiac tissues. Cardiac hypertrophy was assessed as the ratio of left heart ventricle weight to tibia length (LVW/TL). Although tempol and apocynin treatment in TGR significantly decreased 8-isoprostane excretion and MAD tissue concentrations as compared with untreated TGR, it did not alter the course of SBP, LVW/TL ratio, proteinuria or ANG II levels that were enhanced as compared with HanSD rats. Our data suggest that the development of hypertension in TGR is clearly ANG II-dependent but the contribution of oxidative stress to the development of hypertension in this model appears to be negligible.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19539780     DOI: 10.1016/j.vph.2009.06.001

Source DB:  PubMed          Journal:  Vascul Pharmacol        ISSN: 1537-1891            Impact factor:   5.773


  9 in total

1.  High-salt intake enhances superoxide activity in eNOS knockout mice leading to the development of salt sensitivity.

Authors:  Libor Kopkan; Arthur Hess; Zuzana Husková; Ludek Cervenka; L Gabriel Navar; Dewan S A Majid
Journal:  Am J Physiol Renal Physiol       Date:  2010-07-07

Review 2.  The complex interplay between cyclooxygenase-2 and angiotensin II in regulating kidney function.

Authors:  Torrance Green; Alexis A Gonzalez; Kenneth D Mitchell; L Gabriel Navar
Journal:  Curr Opin Nephrol Hypertens       Date:  2012-01       Impact factor: 2.894

Review 3.  Interaction of the renin angiotensin and cox systems in the kidney.

Authors:  Syed S Quadri; Silas A Culver; Caixia Li; Helmy M Siragy
Journal:  Front Biosci (Schol Ed)       Date:  2016-06-01

4.  Antihypertensive action of soluble epoxide hydrolase inhibition in Ren-2 transgenic rats is mediated by suppression of the intrarenal renin-angiotensin system.

Authors:  Sarka Varcabova; Zuzana Huskova; Herbert J Kramer; Sung Hee Hwang; Bruce D Hammock; John D Imig; Kento Kitada; Ludek Cervenka
Journal:  Clin Exp Pharmacol Physiol       Date:  2013-04       Impact factor: 2.557

5.  Antihypertensive actions of moderate hyperbilirubinemia: role of superoxide inhibition.

Authors:  David E Stec; Megan V Storm; Brandon E Pruett; Monette U Gousset
Journal:  Am J Hypertens       Date:  2013-03-12       Impact factor: 2.689

6.  Central angiotensin-(1-7) improves vagal function independent of blood pressure in hypertensive (mRen2)27 rats.

Authors:  Manisha Nautiyal; Hossam A Shaltout; Daniel C de Lima; Kenia do Nascimento; Mark C Chappell; Debra I Diz
Journal:  Hypertension       Date:  2012-10-08       Impact factor: 10.190

7.  Renal nitric oxide synthase and antioxidant preservation in Cyp1a1-Ren-2 transgenic rats with inducible malignant hypertension.

Authors:  Mark W Cunningham; Jennifer M Sasser; Crystal A West; Carlo J Milani; Chris Baylis; Kenneth D Mitchell
Journal:  Am J Hypertens       Date:  2013-06-13       Impact factor: 2.689

8.  Sex differences in blood pressure of aged Ren-2 transgenic rats.

Authors:  H Rauchová; S Hojná; M Kadlecová; I Vaněčková; J Zicha
Journal:  Physiol Res       Date:  2020-03-23       Impact factor: 1.881

9.  Inhibition of soluble epoxide hydrolase is renoprotective in 5/6 nephrectomized Ren-2 transgenic hypertensive rats.

Authors:  Petr Kujal; Vera Čertíková Chábová; Petra Škaroupková; Zuzana Husková; Zdena Vernerová; Herbert J Kramer; Agnieszka Walkowska; Elzbieta Kompanowska-Jezierska; Janusz Sadowski; Kento Kitada; Akira Nishiyama; Sung H Hwang; Bruce D Hammock; John D Imig; Ludek Červenka
Journal:  Clin Exp Pharmacol Physiol       Date:  2014-03       Impact factor: 2.557

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.